Interestingly, histomorphometric analyses of total vimentin+ CAFs [34] in tumor tissues treated by ASA with or without anti-angiogenic agents revealed a 3.4-fold reduction of CAFs upon treatment with ASA alone. The gene discussed is VIM; the disease is neoplasm.